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Abstract
Background: Endometriosis is one of the most common gynecological diseases. It is still a chameleon in many
aspects and urges intense research activities in the fields of diagnosis, therapy and prevention. Despite the need to
foster research in this area, no in-depth analysis of the global architecture of endometriosis research exists yet.
Methods: We here used the NewQIS platform to conduct a density equalizing mapping study, using the Web of
Science as database with endometriosis related entries between 1900 and 2009. Density equalizing maps of global
endometriosis research encompassing country-specific publication activities, and semi-qualitative indices such as
country specific citations, citation rates, h-Indices were created.
Results: In total, 11,056 entries related to endometriosis were found. The USA was leading the field with 3705
publications followed by the United Kingdom (952) and Japan (846). Concerning overall citations and country-specific
h-Indices, the USA again was the leading nation with 74,592 citations and a modified h-Index of 103, followed by the
UK with 15,175 citations (h-Index 57). Regarding the citation rate, Sweden and Belgium were at top positions with rates
of 22.46 and 22.26, respectively. Concerning collaborative studies, there was a steep increase in numbers present;
analysis of the chronological evolution indicated a strong increase in international collaborations in the past 10 years.
Conclusions: This study is the first analysis that illustrates the global endometriosis research architecture. It shows that
endometriosis research is constantly gaining importance but also underlines the need for further efforts and
investments to foster research and ultimately improve endometriosis management on a global scale.
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Background
Endometriosis is one of the most common benign
gynecological diseases affecting 1 in 10 women of child-
bearing age; its management constitutes a daily routine
in the practice of obstetrician/gynecologists [1–3]. In the
United States (USA), it represents the third leading
cause of gynecologic hospitalization, limits workforce
participation and impacts both a woman’s physical and
mental well being [4]. Hence, endometriosis poses a tre-
mendous burden on individual and community health: In
the USA alone, the related total societal costs were pro-
jected at $70 billion in 2009 [5].
Endometriosis is an estrogen-dependent condition char-
acterized by endometrial glands and stroma located out-
side the uterine cavity [6–9]. Implants are found in the
peritoneum, the ovaries and the rectovaginal septum
constituting three different disease entities [10]. Endo-
metriosis is a commonly underdiagnosed condition: Its
epidemiologic assessment is hampered by a high num-
ber of obscure cases in the general population and the
lack of non-invasive diagnostic tools [11, 12]. However,
endometriosis is estimated to have a prevalence of up to
5 % in fertile and 25–40 % in infertile women [8].
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Additionally to debilitating symptoms such as dysmen-
orrhea, chronic pelvic pain and infertility, 8–30 % of
patients will develop endometriosis-associated ovarian
cancer during their lifetime [13–15]. Currently, there is
no cure for endometriosis but several treatment proto-
cols exist for the management of associated sequelae
[8, 16, 17].
Although substantial progress has been achieved
investigating the pathogenesis and pathophysiology of
the disease, endometriosis still belongs to the most
enigmatic and complex conditions in the field of ob-
stetrics and gynecology (OB/GYN). Further multidis-
ciplinary, translational and clinical research is needed
[4, 11, 18] to define disease origins, to develop non-
invasive diagnostic tools and in-vitro models aiming
to evaluate the process of malignant transition as well
as novel treatment approaches [6, 12, 19, 20]. In this
respect, it is commonly accepted that further random-
ized clinical trials, which focus on proposed etio-
pathogenic mechanisms and therapeutic innovation,
are necessary to identify more conclusive, evidence-
based answers [8].
Besides posing a scientific challenge, endometriosis
constitutes a major burden on female health worldwide.
Hence, we deduce that research and public health ef-
forts have to be strengthened to ensure future suc-
cesses. To plan these research endeavors accordingly so
they meet identified shortcomings and to supply deci-
sion makers with information concerning funding strat-
egies, it is the objective of the study to assess the
present scientific performance in the field. The ‘New
Quality and Quantity Indices in Science’ (NewQIS) pro-
ject [21, 22] combines scientometric tools and advanced
density equalizing mapping procedures [23] to depict
the global research architecture and to evaluate
country-specific productivity in the framework of the
scientific landscape. We also aim to guide individual
scholarship and the publication of own research by pre-
senting the 10 most cited articles and the most prolifer-
ative journals in the field of endometriosis research.
Methods
NewQIS protocol
We employed the previously established NewQIS
platform to conduct this study [21, 22]. The method
encompasses the use of advanced visualization algo-
rithms such as Gastner and Newman’s density equal-
izing calculations and scientometric tools in order to
evaluate and visualize endometriosis-associated re-
search activity [21, 22].
Data source
As described previously [24, 25], the database Web of
Science (WoS, Thomson Scientific) was used for data
collection. We based this study on this particular re-
source because WoS provides the unique opportunity
to analyze the global publication activity and to per-
form an in-depth citation analysis, which includes the
calculation of combined semi-qualitative country- and
endometriosis-specific indices such as the modified h-
indices or average citation rates.
Search strategy
In the presented approach, we identified endometriosis-
specific publications by the use of the specific search term
‘(endometrios*)’. The operator * was applied to identify
both singular and plural cases in title, abstract and key
words of all eligible publications listed in the WoS.
Timeframe
The search was performed in 2010; the analyzed time-
frame covered the years between 1900 (01-01) and 2009
(31-12). As discussed in previous studies, results from
2010 onwards were not considered due to incomplete
data acquisition (i.e. citation rate) in order not to ham-
per the global citation analyses.
Data analysis and categorization
All endometriosis-related publications issued in the
timeframe of 110 years were analyzed using our stan-
dardized protocol and categorized with respect to publi-
cation date, country of origin, source title, and authors
[26]. Also, the numbers of citations were retrieved for
each publication and the average citation per item (CR,
citation rate) were calculated as previously described.
After transfer the raw data to excel charts, the findings
were illustrated in diagrams and visualized by density-
equalizing mapping projections (DEMP) [26]. The current
DEMP analysis was based on the algorithm of Gastner
and Newman [23], so the territories of the different coun-
tries publishing endometriosis research were resized in
proportion to our selected variables. In the present con-
text, we used these visualization algorithms to draw a
sketch of worldwide endometriosis-related research activ-
ities illustrating the global distribution of country-specific
numbers of published items and related citation rates.
Analysis of research cooperations
To investigate endometriosis-related research collabora-
tions between the different countries, the affiliations of
the endometriosis-related publications were screened as
earlier described for other diseases [24, 26]. If at least
two authors, attributed to different countries, contrib-
uted to an endometriosis article, this relationship was
defined as a collaborative publication.
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Journal analysis
We evaluated journals publishing endometriosis research
by analyzing quantitative and qualitative aspects, e.g.
number of published endometriosis-specific articles as
well as citations these items received (CR).
Results
Global endometriosis research activity
In total, 11,056 endometriosis-related publications were
identified. These items were published in 20 different lan-
guages: 93.0 % were written in English, 3.4 % in German,
2.3 % in French, and 0.5 % in Spanish, respectively.
Out of 11,056 publications, 10,881 were attributed to
one or more originating countries and issued by authors
from 88 nations. The USA was most productive with
3705 publications (p). It was followed by the United
Kingdom (UK, p: 952), Japan (p: 846), Italy (p: 720),
Germany (p: 715), France (p: 497), Belgium (p: 378),
Canada (p: 375), Australia (p: 270) and Spain (p: 213). In
the DEMP-analysis (Fig. 1a), major parts of Asia in-
cluding Russia and China (with the exception of Japan),
Africa and South America (except Brazil), appear mini-
mized. The DEMP visualizes that North America
clearly constitutes the scientific center of endometriosis
research, followed by Western Europe.
In the analysis of the chronological evolution of endo-
metriosis research (Fig. 1b), a significant increase in an-
nual publication numbers was visible from 1980 onwards.
The steep increase after 1990 can be explained by the fact
that the WoS started to include abstracts of the publica-
tions in the database, which increased the likelihood to
identify endometriosis-related items by topic search. Cor-
respondingly, a larger number of publications and related
citations could be identified in our search. The years with
the highest publication activities included 2007 (746 an-
nual publications), 2009 (739 annual publications) and
2008 (726 annual publications). The highest growth in
publication output was present between 2002 and 2003
with an increase from 428 to 618 %. In the last 10 years of
our analysis spanning 110 years of endometriosis research,
6221 publications were published (equals 56 % of all).
Citation analysis
In the country-specific citation analysis (Fig. 2a), again,
the USA was found to be the leading nation with a total
of 74,592 citations, followed by the UK with 15,175 cita-
tions, Japan with 11,704 citations and Italy with 10,147
citations. DEMP results of total citations resembled the
aforementioned DEMP analysis of total publications
numbers with some minor exceptions, i.e. Belgium was
ranked 5th with 8489 citations (Fig. 2a). In Additional file
1, we compiled the 10 most cited articles in the field.
The calculation of the country-specific citation rate
(citations per endometriosis publication of a country,
with a threshold of 30 publications per country) was
used as a semi-qualitative measure (Fig. 2b). It pointed
to a high average citation of Belgian endometriosis pub-
lications with a citation rate (CR) of 22.46 citations per
single endometriosis publication. Sweden was located in
the second position with a rate of 22.26 followed by
Finland (CR 20.77), the USA (CR 20.13), Norway (CR
19.42), the Netherlands (CR 17.19), Canada (CR 16.69)
and the UK (CR 15.94).
The country- and endometriosis-specific h-Index cal-
culation (Fig. 2c) demonstrated a leading position of the
USA with 103 endometriosis-related publications cited
at least 103 times. The USA is followed by the UK with
a country-specific h-Index (HI) of 57, Belgium (HI 49),
Italy and Japan (HI both 47), France (HI 42) and Canada
(HI 41). Again, countries from Asia (with the exception
of Japan), Africa, Eastern Europe, or Latin America were
characterized by very low citation rates.
Cooperation articles
In the period between 1900 and 2009, 902 of all publica-
tions were based on international collaborative efforts. This
equaled a rather low percentage of 8.15 %. 771 of these
items were issued by bilateral collaborations (85.5 %,
Fig. 3a), followed by trilateral (101 publications) and collab-
orations between four countries (20 publications). Analysis
of the chronological evolution indicated a strong increase
in international collaborations in the past 10 years (Fig. 3b).
Overall, the USA dominated the category of collaborative
efforts in the field of endometriosis research; 493 publica-
tions could be attributed to international cooperations. It
was followed by the UK (197 papers based on international
collaborations out of 952 items in total), Germany (130 pa-
pers based on international collaborations out of 715 items
in total), Belgium (129 papers based on international col-
laborations out of 378 items in total), and Italy (121 papers
based on international collaborations out of 720 items in
total). The USA established 75 bilateral collaborations with
Canada, 61 with Germany and 61 with the UK. Other fruit-
ful collaborations were identified between Belgium and the
UK (39 items), Japan and the USA (38 items), Belgium and
Kenya (34 items), Italy with the UK (34 items) and Italy
with the USA (32 items, Fig. 4a). Among the ten countries
having issued the most cooperation articles in the field, the
percentage of publications based on international collab-
orative efforts were the lowest in Japan (9 %) and the USA
(13 %). Belgium and Sweden constituted notable excep-
tions. These countries published more than a third of their
total research output on endometriosis within the frame-
work of international cooperations (Fig. 4b).
Subject area analysis
Most endometriosis publications were assigned to one
(6151) or two (4592) subject areas (Fig. 5a). We
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identified ‘Obstetrics and Gynecology’ as the most fre-
quently applied subject category with 6634 assignments
followed by ‘Reproductive Biology’ with 3410 assign-
ments. Then, separated by a large gap, ‘Medicine, Gen-
eral & Internal’ was found (806 assignments), followed
by ‘Surgery’ (588 assignments), ‘Pathology’ (532 assign-
ments) and ‘Endocrinology & Metabolism’ (512 assign-
ments) (Fig. 5b). The most frequent combination of two
assigned subject areas was ‘Obstetrics & Gynecology’ with
‘Reproductive Biology’ attributable to 3014 publications.
When focusing on differences in subject areas between
the 15 most productive countries in endometriosis re-
search, no large differences were found.
Journal analysis
The 15 most prolific journals in endometriosis re-
search were identified and illustrated in Fig. 6. “Fertility
and Sterility” was leading the field (1837 articles), followed
by “Human Reproduction” (721 articles) and the “American
Journal of Obstetrics and Gynecology” (501 articles). The
Fig. 1 a Density-equalizing map of total endometriosis publications in each country. The area of each country was scaled in proportion to its total
number of publications. Different colors encode numbers of endometriosis publications. This DEMP figure was generated by the authors as
described in the methods section. b Chronological evolution of endometriosis-related publications. The red dotted line indicates the steep
increase in publication activity visible after 1990
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highest citation rate was achieved by the “Journal of
Clinical Endocrinology and Metabolism” (104 articles,
CR = 48.66).
Discussion
As elegantly described by Kvaskoff et al., the etiology of
endometriosis remains poorly understood despite an es-
timated prevalence of 10 % in women [9]. The authors
stress the fact that many unsolved questions still exist
since endometriosis has been associated with an in-
creased risk of several debilitating and chronic condi-
tions, such as ovarian cancer, asthma, autoimmune,
atopic and cardiovascular diseases [9]. Therefore, it is
commonly accepted that a deeper understanding of
these associations is needed as they may provide novel
insights into the etiology or clinical implications of the
Fig. 2 a Density-equalizing map of country total citations of endometriosis publications. The area of each country was scaled in proportion to its
total number of citations. Colors encode numbers of citations. b Density-equalizing map of country citation rate of endometriosis publications.
The area of each country was scaled in proportion to its citation rate. Colors encode numbers of citations. These DEMP figures were generated
by the authors as described in the methods section
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condition [9]. Thus, research in this field needs a strong
boost with new and profound funding programs to be
initiated by agencies around the world. Since these en-
deavors require a sound underlying basis, we identified
the need for an all-encompassing depiction of the exist-
ing global research landscape and conducted the first de-
tailed analysis of worldwide endometriosis research. So
far, only a few other OB/GYN topics including breast
cancer [7, 27] and smoking and pregnancy [28] were
subjected to a similar in-depth analysis using the New-
QIS platform.
Global endometriosis research is dominated by a small
number of scientific power players: These include the
USA and the UK holding the leading positions in
regards to publication quantity, country-specific citation
numbers and h-Indices. Our data align with other stud-
ies evaluating the scientific productivity in the biomedical
field. Groneberg-Kloft et al. analyzed over 5.5 million
Fig. 3 a International collaborations from 1983 to 2009. b Number of co-authors
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publications related to 22 organ systems and identified the
USA in the top position regarding overall research output
[29]. Comparing our results with other investigations in
the areas of Internal Medicine or OB/GYN in particular
leads to a similar picture: When scientific productivity
was evaluated in regards to “tuberculosis”, bacterial men-
ingitis”, “influenza” as well as “smoking in pregnancy” or
“breast cancer”, the USA and the UK were once again
dominating the field [28, 30–32]. This pattern might point
to the fact that both countries dedicate major financial re-
sources towards biomedical research creating a supportive
scientific infrastructure, e.g. as indicated by the worldwide
highest number of endometriosis research institutions (n:
1293) located in the USA. Also, both nations established
numerous fruitful collaborations facilitating high quality
research. Furthermore, we identified Belgium and Japan as
prominent scientific forces within the endometriosis com-
munity. Japan’s strong interest in the field might be based
Fig. 4 a Number of collaborative items published in a joint effort between two countries dedicated to research in the field of endometriosis.
The figure depicts only cooperations of countries with more than 20 collaborative publications b Proportions of international collaborative efforts
among all publications of the ten most proliferative countries in endometriosis research
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on the fact that prevalences of endometriosis and asso-
ciated clear-cell ovarian cancers are estimated to be
the worldwide highest among Asian - and particularly
Japanese - women [33, 34]. Therefore, the nation prior-
itizes related research with the aim to alleviate the as-
sociated disease burden for its inhabitants. For many
years, Belgian scientists (e.g. at the University of Leuven)
have been focusing on endometriosis research. Their
efforts translated into numerous highly regarded publica-
tions as documented by the highest country-specific cit-
ation rate this nation received in our analysis. Concerning
country-specific citation rates, we also found three Scandi-
navian countries (Sweden, Finland and Norway) among
the five leading nations indicating the outstanding quality
and high recognition of their publications. This finding
might be linked to the vast data resources these countries
Fig. 5 a Distribution of subject area assignments per endometriosis publication. b Most frequently assigned subject areas
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established (e.g. The Swedish National Patient Register),
which enable researchers to conduct meaningful and
highly cited key studies in the field.
The need for an assessment of the worldwide endomet-
riosis research architecture becomes even more pressing
when the limited number of studies with a global perspec-
tive on endometriosis is compared with the fact that this
enigmatic disease heavily affects female health in a global
context - ranging from high income to low income coun-
tries and all ethnicities. In this respect, Nnoaham et al.
stressed that little is known about the impact of endomet-
riosis across the world [35]. Therefore, they initiated inte-
grated multicenter studies to collect prospective,
standardized, epidemiological data, to 1) examine the glo-
bal impact of endometriosis and relative effect of risk-
factors, and 2) develop a symptom-based diagnostic tool
[35]. Their studies encompassed 19 hospitals in 13 coun-
tries [36, 37]. In one study, the authors assessed the im-
pact of endometriosis on mental, physical and social well
being and concluded that endometriosis impairs health-
related quality of life and work productivity significantly
across countries and ethnicities, yet women continue to
experience diagnostic delays in primary care [37]. These
findings stress the need for further multinational ap-
proaches, especially also with the participation of low
income countries in which millions of women suffer
from undiagnosed and insufficiently treated endometri-
osis. This claim is substantiated by our presented data:
A closer look into the global endometriosis research
architecture exemplifies that a large gap of research ac-
tivity exists in a multitude of countries in which – under
conservative estimations – tens of millions of affected
women live, e.g. in China, India (BRIC countries – nations
at a similar stage of newly advanced economic develop-
ment - with established research infrastructures that could
be instantly used for endometriosis research) and African
countries. These numbers are mirrored by an extremely
low number of endometriosis publications originating
from these countries. This disparity verifies that research
in this field is simply not a priority in developing or under-
developed countries. Overall, research on the endometri-
osis in low resource countries is extremely scarce. Kyama
et al. reflected on the problem of endometriosis in women
living on the African continent and concluded in 2007
that research programs have to be developed and estab-
lished to tackle the local unique challenges the condition
creates [38]. The authors point out that rates of endomet-
riosis are reported to be lower in African women com-
pared with females in industrialized countries. They
attributed this finding to an epidemiological under-
estimation since the locally perceived need for accurate
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Fig. 6 The 15 most prolific journals in endometriosis research with number of articles, number of citations and citation rate
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of both patients and doctors, restricted access to health-
care and surgical resources as well as a protective lifestyle
(e.g. earlier childbearing, high parity). Our study further
verifies the clear lack of research activity in countries of
low-resources and reinforces Kyama’s call to action in
particular. Hence, it would be key to extent the world-
wide increasing collaborative efforts and involve these
underserved nations with the aim to share data, resources
and knowledge. In this context, we have to mention one
exception, Kenya, showcasing successful international col-
laborative endeavors: This African nation has established
41 co-operations with other countries (e.g. with Belgium).
As early as 1968, spontaneous endometriosis was reported
in baboons [39, 40]. Since then, these monkeys, which are
housed in the “Institute of Primate Research” in Nairobi
(http://www.primateresearch.org), serve as an invaluable
animal model in the field of endometriosis research lead-
ing to many milestone publications in the field [41–49].
Several methodological issues need to be discussed
when interpreting the present data: 1) As an important
strength of this study, the NewQIS platform constitutes
an established protocol to assess basic and clinical sci-
ences benchmarks in a standardized and verified way. So
far, it was primarily used i.e. within the areas of public
health [29, 50–53] and internal medicine [32, 54]. Now,
it has been extended to OB/GYN; in this field, many dis-
eases are treated that pose a major thread on female and
pediatric well-being and have large public health impli-
cations. 2) Our platform is configurated to access the
WoS database instead of PubMed. Therefore, differences
in the overall number of identified endometriosis publi-
cations can be expected. This finding can be explained
by the differing set of journals enlisted in both databases.
However, we prefer to work with WoS as the primary
database since it enables the user to integrate a concise
citations analysis. This unique feature allowed us to
perform valuable multifaceted semi-qualitative ap-
proaches, i.e. by calculating endometriosis-specific,
country-specific h-indices or average citation rates. 3)
A language bias constitutes a mentionable weakness of the
presented NewQIS analysis: Clearly, the WoS - but also
the PubMed - does not automatically index every Non-
English scientific journal. By contrast, other databases
such as Scopus include them. Since the majority of jour-
nals included in the WoS - and therefore analyzed in our
search - are written in English an underrepresentation of
non-English publications can be assumed. Especially in
the area of public health and epidemiology, which are
often focused on country-specific, national issues, there
may be non-English endometriosis studies that are not
traceable in the WoS. However, we consider this language
bias as limited because data of outstanding interest and
quality will be published in WoS-listed scientific journals
and therefore included in our search.
Conclusion
This is the first study to delineate a picture of the global
research landscape of one of the most enigmatic diseases
present in OB/GYN. In this area of medicine, the USA
plays the leading role for the advancement of science. It
is the country with the highest number of highly cited
endometriosis publications and it shares the highest num-
ber of collaborations with other countries. It is also note-
worthy that small Northern European countries such as
Belgium, Finland and Sweden, seem to dedicate many re-
sources in relation to their low numbers of inhabitants.
An intensification of research efforts is needed to battle
pressing challenges on a global scale such as the malignant
transition of endometriosis or the development of novel
non-invasive diagnostic tests and treatment approaches in
order to improve disease management for millions of af-
fected women in industrialized and developing countries.
In this context, it should be a priority of supranational in-
stitutions such as the WHO or private funding organiza-
tions to provide the much needed monetary support.
Additional file
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table depicts the ten most cited articles in the area of endometriosis
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origin, citation count and journal. (DOCX 113 kb)
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